Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Psychol Health. 2017 Mar 30;32(7):826–842. doi: 10.1080/08870446.2017.1307372

Table 1.

Characteristics of Participants (N=104)

Characteristic Total Sample Written Disclosure Control Group
N (%) N (%) N (%)
Age (Median [IQR]), Years 58.0 (51.6–65.4) 56.8 (49.2–62.1) 58.3 (52.9–68.7)
Race
 White 87 (83.7) 40 (78.4) 47 (88.7)
 African American 14 (13.5) 10 (19.6) 4 (7.5)
 Other 3 (2.9) 1 (2.0) 2 (3.8)
Marital Status
 Married/Partnered 76 (73.1) 33 (64.7) 43 (81.1)
 Other 28 (26.9) 18 (35.3) 10 (18.9)
Education
 ≤ 12th Grade 24 (23.1) 12 (23.5) 12 (22.6)
 > 12th Grade 80 (76.9) 39 (76.5) 41 (77.4)
Household income, US $
 ≤ 30,000 9 (8.6) 6 (11.8) 3 (5.7)
 30,000–60,000 29 (27.9) 13 (25.5) 16 (30.2)
 > 60,000 55 (52.9) 26 (51.0) 29 (54.7)
 Did not care to answer 11 (10.6) 6 (11.8) 5 (9.4)
Body Mass Index (Median [IQR]) 28.9 (25.8–35.0) 29.9 (25.1–35.2) 28.6 (26.0–34.4)
Stage at Diagnosis
 I 24 (23.85) 11 (22.4) 13 (25.0)
 II 58 (57.4) 29 (59.2) 29 (55.8)
 III 18 (17.8) 8 (16.3) 10 (19.2)
 IV 1 (1.0) 1 (2.0) 0 (0.0)
Surgery Type
 Lumpectomy/segmental 41 (40.2) 20 (40.0) 21 (40.4)
 Mastectomy 56 (54.9) 26 (52.0) 30 (57.7)
 Other 5 (4.9) 4 (8.0) 1 (1.9)
Chemotherapy 85 (83.3) 42 (84.0) 43 (83)
Radiotherapy 67 (65.7) 34 (68.0) 33 (63.5)
Lymphedema duration (Median [IQR]), Years 3.7 (0.9–8.3) 3.8 (0.9–8.4) 3.7 (0.8–8.3)
Mode of intervention implementation
  Hand written 30 (28.8) 14 (27.5) 16 (30.2)
  Computer 74 (71.2) 37 (72.5) 37 (69.8)

Notes. IQR=interquartile range. No statistically significant differences between the study groups were observed (p > 0.05).